Adamis Pharmaceuticals is a clinical stage neuro-biotechnology company committed to patients. Our commercial and development products aim to address areas of significant unmet medical need.
ZIMHI Technology – watch our video that explains how it works
Adamis Pharmaceuticals is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease.
Commercially approved products:
The following molecules are in development:.
Want to learn more?
Read our press release go to our Investor Relations page or visit https://dmkpharma.com/
Check this page for the most recent updates regarding the merger process.